SEALSQ CORP
LAESNASDAQTrading Snapshot
- Day Range
- $2.37 – $2.40
- 52-Week Range
- $1.99 – $8.71
- Volume
- $1.78B
- Avg Volume
- $2.19B
- Shares Outstanding
- 142.6M
- Next Earnings
- Dec 3, 2026
Fundamentals Snapshot
- Annual Revenue
- $18M
- Last Q Revenue
- $14M
- P/E Ratio
- -9.5
- P/S Ratio
- 12.6x
- EPS (TTM)
- $-0.21
- Dividend Yield
- 0.00%
- Dilution (1yr)
- +217.6%
Why Investors Own LAES
- ✓High-growth profile — revenue up +35.0% YoY with expanding US Equity exposure.
- ✓Healthy economics — 49% gross margin and 25% free-cash-flow margin.
- ✓New products and segments could unlock additional revenue streams.
Execution delays, intensifying competition, and valuation compression if growth decelerates.
SEALSQ CORP
LAES
StockOtter · stockotter.spaceAbout SEALSQ CORP
SEALSQ Corp, a subsidiary of WISeKey International Holding AG, was founded in 2022 and operates out of Cointrin, Switzerland. The company specializes in the creation and distribution of semiconductor components, serving both governmental and commercial entities. Its offerings encompass a range of semiconductors and smart card reader chips, alongside services for identity management and managed Public Key Infrastructure (PKI) solutions tailored for Internet of Things (IoT) applications. SEALSQ Corp's clientele spans diverse industries, including consumer electronics, aerospace and defense, satellite communications, smart energy and building management, industrial automation, logistics, medical technology, and the broader consumer market.
Otter Score Breakdown
How it's scoredFive components, each rated 1–5★ and equally weighted (20%), averaged to a 0–100 score:💎 Quality — gross margin🚀 Growth — revenue YoY⚖️ Valuation — P/S ratio⚡ Momentum — 30-day price change💧 Dilution — 1-yr share issuance (buybacks score higher)Analyst Ratings
ⓘLatest News & Updates
SEALSQ Highlights Its Subsidiary IC'Alps' Low-Power, Secure ASIC Design Expertise for Implantable and Connected Medical Devices
Geneva, Switzerland, Sept. 30, 2026 (GLOBE NEWSWIRE) -- Featured in the DeviceMed Buyer's Guide 2026–2027, IC'Alps develops custom integrated circuits for medical technology applications where ultra-low-power operation,
SEALSQ Leverages NIST FIPS 140-3 Level 3 Validation to Accelerate Government, Critical-Infrastructure and Post-Quantum Hardware-Security Programs; Provides Updated Certification and Commercialization Timetable
Active validation strengthens SEALSQ's position in government, defense, critical infrastructure, industrial IoT and other highly regulated markets requiring independently validated hardware security Active validation str
SEALSQ and WISeKey Expand Quantum Highway™, Connecting Sovereign Technology Centers from Silicon to Quantum and Space
Geneva, Switzerland, Sept. 22, 2026 (GLOBE NEWSWIRE) -- SEALSQ Corp (NASDAQ: LAES) ("SEALSQ" or "Company"), a company that focuses on developing and selling Semiconductors, PKI, and Post-Quantum technology hardware and s
WISeKey, SEALSQ and Canton of Jura Sign MoU to Establish a Swiss Post-Quantum Semiconductor and Cybersecurity Center
WISeKey, SEALSQ and Canton of Jura Sign MoU to Establish a Swiss Post-Quantum Semiconductor and Cybersecurity Center Proposed CHF 40-60 million public-private initiative aims to establish sovereign semiconductor personal
SEALSQ, WISeKey and Canton of Jura Sign MoU to Establish a Swiss Post-Quantum Semiconductor and Cybersecurity Center
DELÉMONT, Switzerland, Sept. 21, 2026 (GLOBE NEWSWIRE) -- Proposed CHF 40-60 million public-private initiative aims to establish sovereign semiconductor personalization capabilities in Switzerland and create up to 250+ d
iMTC Technology Selects SEALSQ TPM183 for Next-Generation Fingerprint Recognition Medical Mouse
Geneva, Switzerland and Taipei, Taiwan, Sept. 17, 2026 (GLOBE NEWSWIRE) -- Design win brings QVault TPM183 into commercial production designs and extends SEALSQ's established healthcare franchise from medical devices to